Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah, USA.
Division of Pediatric Endocrinology, Baystate Children's Hospital - UMASS Chan Medical School - Baystate, Springfield, Massachusetts, USA.
Pediatr Diabetes. 2022 Nov;23(7):926-943. doi: 10.1111/pedi.13392. Epub 2022 Sep 4.
Diabetes is an increasingly common chronic metabolic disorder in children worldwide. The discovery of insulin in 1921 resulted in unprecedented advancements that improved the lives of children and youth with diabetes. The purpose of this article is to review the history of diabetes in children and youth over the last century and its implications for future developments in the field. We identified 68 relevant events between 1921 and 2021 through literature review and survey of pediatric endocrinologists. Basic research milestones led to the discovery of insulin and other regulatory hormones, established the normal physiology of carbohydrate metabolism and pathophysiology of diabetes, and provided insight into strategies for diabetes prevention. While landmark clinical studies were initially focused on adult diabetes populations, later studies assessed etiologic factors in birth cohort studies, evaluated technology use among children with diabetes, and investigated pharmacologic management of youth type 2 diabetes. Technological innovations culminated in the introduction of continuous glucose monitoring that enabled semi-automated insulin delivery systems. Finally, professional organizations collaborated with patient groups to advocate for the needs of children with diabetes and their families. Together, these advances transformed type 1 diabetes from a terminal illness to a manageable disease with near-normal life expectancy and increased our knowledge of type 2 diabetes and other forms of diabetes in the pediatric population. However, disparities in access to insulin, diabetes technology, education, and care support remain and disproportionately impact minority youth and communities with less resources. The overarching goal of diabetes management remains promoting a high quality of life and improving glycemic management without undermining the psychological health of children and youth living with diabetes.
糖尿病是一种在全球范围内日益普遍的儿童慢性代谢性疾病。1921 年胰岛素的发现带来了前所未有的进步,改善了儿童和青少年糖尿病患者的生活。本文的目的是回顾过去一个世纪儿童和青少年糖尿病的历史及其对该领域未来发展的影响。我们通过文献回顾和对儿科内分泌学家的调查,确定了 1921 年至 2021 年期间的 68 项相关事件。基础研究的里程碑导致了胰岛素和其他调节激素的发现,确立了碳水化合物代谢的正常生理学和糖尿病的病理生理学,并为糖尿病预防策略提供了深入了解。虽然里程碑式的临床研究最初侧重于成人糖尿病人群,但后来的研究在出生队列研究中评估了病因因素,评估了儿童糖尿病患者的技术使用情况,并研究了青少年 2 型糖尿病的药物管理。技术创新最终导致了连续血糖监测的引入,从而实现了半自动胰岛素输送系统。最后,专业组织与患者团体合作,倡导满足糖尿病儿童及其家庭的需求。这些进展共同将 1 型糖尿病从一种绝症转变为一种可管理的疾病,使患者接近正常的预期寿命,并增加了我们对儿科人群中 2 型糖尿病和其他形式糖尿病的了解。然而,获得胰岛素、糖尿病技术、教育和护理支持的机会仍然存在差距,并且不成比例地影响到资源较少的少数族裔青年和社区。糖尿病管理的总体目标仍然是在不损害患有糖尿病的儿童和青少年的心理健康的情况下,促进高质量的生活并改善血糖管理。